Cipla Ltd
CIPL.NS- Latest Trade
- trading lower1,030.1INR
- Change
- -2.1
- % Change
0.20%Negative
- As of Aug 19 2022. Values delayed up to 15 minutes
- Day Range
- 1,020.10 - 1,036.60
- 52-Week Range
- 850.00 - 1,083.00
- Previous Close
- 1,032.20
- Open
- 1,029.05
- Volume
- 654,004.00
- 3 Month Average Trading Volume
- 33.27
- Shares Out (Mil)
- 807.00
- Market Cap
- 832,977.60
- Forward P/E
- 26.57
- Dividend Yield
- 0.48
Key Statistics
1.87179487 mean rating - 39 analysts
- P/E Excl. Extra Items (TTM)
- 33.51
- Price To Sales (TTM)
- 3.85
- Price To Book (Quarterly)
- -99,999.99
- Price To Cash Flow (Per Share TTM)
- 23.14
- Total Debt/Total Equity (Quarterly)
- -99,999.99
- Long Term Debt/Equity (Quarterly)
- -99,999.99
- Return On Investment (TTM)
- -99,999.99
- Return On Equity (TTM)
- -99,999.99
2021 (millions USD)
About Cipla Ltd (CIPL.NS)
Company Information
Cipla Limited is an India-based company that is primarily engaged in the business of pharmaceuticals. The Company’s segments include Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in developing, manufacturing, selling and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a consumer healthcare, Biosimilars and specialty business. Its product portfolio spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The Company's geographical segments include India, the United States, South Africa and Rest of the World. The Company has its network of manufacturing, trading and other incidental operations in India and International markets. The Company has approximately 46 manufacturing sites.
Address
Mumbai CentralMUMBAI,
400013
India
Industry
Biotechnology & Drugs
Executive Leadership
- Yusuf K. Hamied
- Non-Executive Chairman of the Board
- Umang Vohra
- Global Chief Executive Officer, Managing Director, Executive Director
- Samina Hamied
- Executive Vice Chairman of the Board
- M. K. Hamied
- Non-Executive Vice Chairman of the Board
- Ashish Adukia
- Global Chief Financial Officer
- Paul Miller
- CEO Cipla South Africa and Regional Head Africa and Access
- Geena Malhotra
- Global Chief Technology Officer
- Pradeep Bhadauria
- Global Chief Scientific Officer
- Rajendra Chopra
- Compliance Officer, Company Secretary
- Swapn Malpani
- Global Head Supply Chain
- Raju Mistry
- Global Chief People Officer
- Ranjana Pathak
- Global Head of Quality - Medical Affairs and Pharmacovigilance
- Adil Zainulbhai
- Non-Executive Lead Independent Director
- S. Radhakrishnan
- Non-Executive Non-Executive Director
- Mandar Purushottam Vaidya
- Independent Director
- Punita Lal
- Independent Non-Executive Director
- Peter Mugyenyi
- Independent Non-Executive Director
- Ramesh Prathivadibhayankara Rajagopalan
- Independent Non-Executive Director
- Ashok Sinha
- Independent Non-Executive Director
- Robert Stewart
- Independent Non-Executive Director
Latest News
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,750.00 | 0.30%Negative |
| Copper | 672.75 | 0.30%Positive |
| Brent Crude Oil | 94.73 | 1.93%Negative |
| CBOT Soybeans | 1,485.00 | 0.70%Negative |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,283.74 | -- |
| Euro STOXX 50 | 3,748.62 | 0.76%Negative |
| FTSE 100 | 7,555.66 | 0.18%Positive |
| Nikkei 225 | 28,930.33 | 0.04%Negative |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes